.svg){kind=logo}
FreeStyle Libre 2 System
See patients' complete glycaemic profile^ with the FreeStyle Libre 2 system
Now with real-time glucose readings sent right to your patients’ smartphones◊,II
Managing diabetes with confidence
The #1 sensor-based glucose monitoring system used worldwide1
With the FreeStyle Libre 2 system, your patients get real-time glucose readings using the LibreLink app◊,II to help them manage their diabetes more confidently.6
Real-time glucose readings
sent right to your patients smartphone◊,II every minute
Excellent 14-day accuracy
with 9.2% overall MARD2,7
Easy connections
Patients can easily share their glucose readings with you₼ and their family members§
Significant outcomes
for T1D3 and T2D4,5
Real-time glucose readings & alarms
Optional glucose alarms¤
provide a safety check every single minute
provide a safety check every single minute
Accuracy
The FreeStyle Libre 2 system has excellent 14-day accuracy2,7
The FreeStyle Libre 2 system has 9.2% overall MARD with 99.9% of readings in Zones A and B of the Consensus Error Grid without the need for finger prick calibration.
Easy connections
LibreView
Glucose data are automatically uploadedΔ from patients’ LibreLink app◊ to LibreView₼
LibreView₼ is a secure9 cloud-based platform that provides you and your staff access to patient glucose reports to make more informed treatment decisions and support effective diabetes management.
With the LibreLink, patients' glucose readings can be automatically uploadedΔ to LibreView. This means that you can see your patients' complete glycaemic picture to have more informed virtual and in-person treatment conversations. Patients can scan to fill in up to 8 hours of missing data, so your patients’ glucose history is complete.
Significant outcomes for T1D and T2D
The FreeStyle Libre 2 system is proven to have significant clinical and real-world benefits for patients with T1D and T2D MDIs
Clinical outcomes for T1D
2.2 hours
more time in range*
vs SMBG at 6 months of use3
* Time in Range between 3.9-10.0 mmol/L
SMBG = self-monitored blood glucose
0.5%
reduction in HbA1c*
vs SMBG at 6 months of use3
* Primary end point: 0.5% greater HbA1c reduction with the FreeStyle Libre 2 system vs SMBG
SMBG = self-monitored bloog glucose
p<0.001
43 minutes
less time in hypoglycaemia per day*
vs SMBG at 6 months of use3
* Hypoglycaemia measured at <3.9 mmol/L
SMBG = self-monitored bloog glucose
Real-world benefits for T2D MDIs
0.9%
reduction in HbA1c4
over 3-6 months4
p<0.001
43%
less time in hypoglycaemia per day5
(p=0.0006)
<3.9 mmol/L
How the FreeStyle Libre 2 system works
The FreeStyle Libre 2 system is made up of the Libre 2 sensor and the LibreLink app◊
Real-time glucose readings
Sent automaticallyǁ to your patients' smartphone◊
Excellent accuracy
Even in the low glucose range7
Easy and painless
Easy way to check glucose with a painless 1-second scan5
No finger pricks
No finger pricks† — Patients can manage their diabetes painlessly5
Compatible Products
LibreLink App
Real-time glucose readings from the Libre 2 sensor are automaticallyǁ updated every minute and sent directly to the FreeStyle LibreLink app◊ on your patients' smartphones.
LibreView
Using LibreView,₼ our secure9 cloud-based system, patients can upload their data to share with their doctor and care team. You will be able to access more in-depth reports to support you in making treatment decisions for your patients.
LibreLinkUp
With the free LibreLinkUp§ app, your patients’ family members get real-time access to their glucose information and customisable alarms.
References & Disclaimers
Images are for illustrative purposes only. Not real patient or data.
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink may require registration with LibreView.
ǁ Glucose readings are automatically displayed in the FreeStyle LibreLink app only when your patients’ smartphone and sensor are connected and in range.
^ Unger, J. Postgraduate Medicine (2020): https://doi.org/10.1080/00325481.2020.1744393.
¤ Notifications will only be received when alarms are turned on and the sensor is within 20ft unobstructed of the reading device. You must have override do not disturb settings enabled to receive alarms and alerts on your smartphone.
† Finger pricks are required if glucose readings and alarms do not match symptoms or expectations.
Δ Sharing of glucose data requires registration with LibreView. Automatic upload requires a wireless internet connection or mobile data connection.
₼ The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose device data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.
‡ 60-minute warm-up required when applying the sensor.
₸ Sensor is water resistant in up to 1 metre (3 feet) of water for a maximum of 30 minutes. Do not immerse longer than 30 minutes. Not to be used above 10,000 feet.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.LibreLinkUp.com for more information about device compatibility before using the app. Use of LibreLinkUp requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
1. Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre portfolio compared to the number of users for other leading personal use sensor-based glucose monitoring systems.
2. FreeStyle Libre 2 system Performance Data Sheet.
3. Leelarathna, L. N Engl J Med. (2022): DOI: 10.1056/NEJMoa2205650.
4. Kröger J, et al. Three European retrospective real-world chart review studies to determine the effectiveness of flash glucose monitoring on HbA1c in adults with type 2 diabetes. Diabetes Ther 2020;11(1):279–91.
5. Haak T, et al. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther 2017;8(1):55–73.
6. Fokkert M. BMJ Open Diab Res Care (2019): http://dx.doi.org/10.1136/bmjdrc-2019-000809.
7. Alva, Shridhara, Timothy Bailey, Ronald L. Brazg, Erwin S. Budiman, Kristin Castorino, Mark P. Christiansen, Gregory Forlenza, Mark Kipnes, David R. Liljenquist, and Hanqing Liu. “Accuracy of a 14-Day Factory-Calibrated Continuous Glucose Monitoring System with Advanced Algorithm in Pediatric and Adult Population With Diabetes. Journal of Diabetes Science and Technology, (September 2020). http://doi.org/10.1177/1932296820958754.
8. The Bluetooth® word mark and logos are registered trademarks owned by Bluetooth SIG, Inc. and any use of such marks by Abbott is under license.
9. LibreView is ISO27001/27018/27701 certified and HITRUST CSF Certified.
ADC-77355 v3.0
Stay connected